Jang Y
Cancers (Basel). 2025; 17(5).
PMID: 40075756
PMC: 11898591.
DOI: 10.3390/cancers17050909.
Jang Y, Kim C
Nutrients. 2024; 16(23).
PMID: 39683509
PMC: 11644559.
DOI: 10.3390/nu16234115.
Batliner M, Schumacher F, Wigger D, Vivas W, Prell A, Fohmann I
mBio. 2024; 15(8):e0073224.
PMID: 38953353
PMC: 11323541.
DOI: 10.1128/mbio.00732-24.
Jamjoum R, Majumder S, Issleny B, Stiban J
Front Physiol. 2024; 14:1229108.
PMID: 38235387
PMC: 10791800.
DOI: 10.3389/fphys.2023.1229108.
Afrin F, Mateen S, Oman J, Lai J, Barrott J, Pashikanti S
Cancers (Basel). 2023; 15(18).
PMID: 37760612
PMC: 10527029.
DOI: 10.3390/cancers15184645.
Targeting the Sphingolipid Rheostat in Gliomas.
Zaibaq F, Dowdy T, Larion M
Int J Mol Sci. 2022; 23(16).
PMID: 36012521
PMC: 9408832.
DOI: 10.3390/ijms23169255.
Involvement of Ceramide Metabolism in Cerebral Ischemia.
Ouro A, Correa-Paz C, Maqueda E, Custodia A, Aramburu-Nunez M, Romaus-Sanjurjo D
Front Mol Biosci. 2022; 9:864618.
PMID: 35531465
PMC: 9067562.
DOI: 10.3389/fmolb.2022.864618.
Human Brain Lipidomics: Pilot Analysis of the Basal Ganglia Sphingolipidome in Parkinson's Disease and Lewy Body Disease.
Beger A, Dudzik B, Woltjer R, Wood P
Metabolites. 2022; 12(2).
PMID: 35208260
PMC: 8875811.
DOI: 10.3390/metabo12020187.
"Fix and Click" for Assay of Sphingolipid Signaling in Single Primary Human Intestinal Epithelial Cells.
Gallion L, Wang Y, Massaro A, Yao M, Petersen B, Zhang Q
Anal Chem. 2022; 94(3):1594-1600.
PMID: 35020354
PMC: 8931668.
DOI: 10.1021/acs.analchem.1c03503.
Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?.
Duflot T, Tu L, Leuillier M, Messaoudi H, Groussard D, Feugray G
Metabolites. 2021; 11(11).
PMID: 34822442
PMC: 8621392.
DOI: 10.3390/metabo11110784.
Accumulation of Cerebrospinal Fluid Glycerophospholipids and Sphingolipids in Cognitively Healthy Participants With Alzheimer's Biomarkers Precedes Lipolysis in the Dementia Stage.
Fonteh A, Chiang A, Arakaki X, Edminster S, Harrington M
Front Neurosci. 2021; 14:611393.
PMID: 33390893
PMC: 7772205.
DOI: 10.3389/fnins.2020.611393.
Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect Proliferation and Viability of Hepatocellular Carcinoma In Vitro.
Jakobi K, Beyer S, Koch A, Thomas D, Schwalm S, Zeuzem S
Int J Mol Sci. 2020; 21(7).
PMID: 32244391
PMC: 7177910.
DOI: 10.3390/ijms21072409.
Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells.
Bergqvist F, Ossipova E, Idborg H, Raouf J, Checa A, Englund K
Front Pharmacol. 2019; 10:636.
PMID: 31231223
PMC: 6567928.
DOI: 10.3389/fphar.2019.00636.
Approaches for probing and evaluating mammalian sphingolipid metabolism.
Snider J, Luberto C, Hannun Y
Anal Biochem. 2019; 575:70-86.
PMID: 30917945
PMC: 6498843.
DOI: 10.1016/j.ab.2019.03.014.
The role of dihydrosphingolipids in disease.
Magaye R, Savira F, Hua Y, Kelly D, Reid C, Flynn B
Cell Mol Life Sci. 2018; 76(6):1107-1134.
PMID: 30523364
PMC: 11105797.
DOI: 10.1007/s00018-018-2984-8.
Vitamin E δ-tocotrienol inhibits TNF-α-stimulated NF-κB activation by up-regulation of anti-inflammatory A20 via modulation of sphingolipid including elevation of intracellular dihydroceramides.
Yang C, Jiang Q
J Nutr Biochem. 2018; 64:101-109.
PMID: 30471562
PMC: 6363855.
DOI: 10.1016/j.jnutbio.2018.10.013.
Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment.
Jang Y, Rao X, Jiang Q
J Nutr Biochem. 2017; 46:49-56.
PMID: 28456081
PMC: 5635819.
DOI: 10.1016/j.jnutbio.2017.04.003.
Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
McNaughton M, Pitman M, Pitson S, Pyne N, Pyne S
Oncotarget. 2016; 7(13):16663-75.
PMID: 26934645
PMC: 4941342.
DOI: 10.18632/oncotarget.7693.
Producing human ceramide-NS by metabolic engineering using yeast Saccharomyces cerevisiae.
Murakami S, Shimamoto T, Nagano H, Tsuruno M, Okuhara H, Hatanaka H
Sci Rep. 2015; 5:16319.
PMID: 26573460
PMC: 4647206.
DOI: 10.1038/srep16319.
Dihydroceramides: From Bit Players to Lead Actors.
Siddique M, Li Y, Chaurasia B, Kaddai V, Summers S
J Biol Chem. 2015; 290(25):15371-15379.
PMID: 25947377
PMC: 4505450.
DOI: 10.1074/jbc.R115.653204.